Ayurvedic formulation in the management of COVID patients in rural India

A Randomized double blind placebo controlled trial to determine the therapeutic efficacy of AYUSH medicine NOQ19 in treatment of symptomatic COVID-19 patients along with standard allopathic treatment

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037442

Enrollment

100

Registered

2021-10-21

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Symptomatic COVID-19 Infection with or without comorbidities. Willingness to participate in the Study Indian Nationals

Exclusion criteria

Exclusion criteria: Age less than 18 years and age above 65 years. Patients not willing to participate in the study. Pregnancy and Lactation

Design outcomes

Primary

Measure	Time frame
Rate of recovery as measured by RT-PCRTimepoint: Baseline, Day3, Day7, Day 10	—

Secondary

Measure	Time frame
To note improvement in blood biomarkers (CRP, CBC), LFT & KFTTimepoint: Day 0,7	—

Countries

India

Contacts

Public ContactSaumya Subramanian

Sri Sri Institute for Advanced Research

saumya.subramanian@ssiar.org

Outcome results